Address: 2266 Chino Roces Avenue, Makati City 1231,Philippines
Tel: +632 892-0761
GSK is the largest multinational pharmaceutical and healthcare company in the Philippines. The Company stands on three strong pillars namely, the pharmaceuticals, consumer healthcare, and vaccines. It is the market leader in the areas of anti-infectives, respiratory, and vaccines. Consumer healthcare adds breadth to GSK’s product offering. GSK is the 4th leading company in this sector.
GSK has its own manufacturing facility located at Don Celso Tuason Avenue, Cainta, Rizal to supply both pharmaceutical and consumer healthcare products for domestic and international consumption. It is the largest MNC manufacturing facility in the country.
Prescription medicines: Our pharmaceutical products include treatments for asthma, bacterial infection, depression, migraine, diabetes, heart failure and digestive conditions.
Vaccines: We also market vaccines to protect against illnesses such as influenza, rotavirus, hepatitis A and B, diphtheria, tetanus, typhoid, chicken pox and meningoccimia. Over 1300 of our scientists are dedicated to developing new vaccines.
Consumer health: We bring dental health products and over-the-counter medicines to millions of Filipinos and among these are Astring O Sol, Sensodyne, Aquafresh, Calpol and Dequadin.
GSK is currently the world’s fourth biggest pharmaceutical company. What is the positioning of GSK in the Philippines? GSK is the market leader among the multinational pharma companies in the…
Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are…
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant challenge to the innovative medicines industry but also…
“The IMS Health figures show around three to four percent growth in the marketplace,” remarks Raymund Azurin, chief executive of Zuellig Pharma Philippines, “but we are now at a…
Before the introduction of universal healthcare (UHC), most major private hospitals in the Philippines had to rely on imported products. With the MNCs showing only limited interest in small volumes,…
The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal…
Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major…
Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges…
Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and…
Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall…
Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines,…
Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
See our Cookie Privacy Policy Here
